Islay Capital Management, LLC Gilead Sciences, Inc. Transaction History

Islay Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 08, 2022	SELL	$57.72 - $65.01 $98,585 - $111,037	-1,708 Closed	0 $0
Q1 2022 Apr 28, 2022	BUY	$57.92 - $72.58 $98,927 - $123,966	1,708 New	1,708 $102,000
Q4 2021 Feb 08, 2022	SELL	$64.88 - $73.64 $112,956 - $128,207	-1,741 Closed	0 $0
Q3 2021 Oct 18, 2021	SELL	$67.69 - $73.03 $2,369 - $2,556	-35 Reduced 1.97%	1,741 $122,000
Q2 2021 Aug 02, 2021	BUY	$63.47 - $69.35 $112,722 - $123,165	1,776 New	1,776 $122,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Islay Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Islay Capital Management, LLC with notifications on news.